ascopubs.org4d
Performance of a blood-based test for colorectal cancer screening adjusted to the US census age and sex distribution.
Final analysis of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13). Single-cycle neoadjuvant ...
ascopubs.org8d
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...
ascopubs.org14d
Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org11d
Treatment of Pleural Mesothelioma: ASCO Guideline Update
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
ascopubs.org4d
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer.
Comprehensive analysis of Native Hawaiians and other Pacific Islanders with early-onset colorectal cancer. Univariate and multivariate analysis of time from diagnosis to treatment.
ascopubs.org4d
Evaluating the safety of immune checkpoint inhibitors prior to liver transplant.
Development and regulatory approval of a new systemic targeted therapy for advanced hepatocellular carcinoma. Part 1: ICI cohort descriptive analysis. N (%); Median (IQR); Part 2: Comparison between ...
ascopubs.org15d
Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records
Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response ...
ascopubs.org9d
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French Cohorts Patients had squamous ...
ascopubs.org14d
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan
Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Colorectal Cancer: ...
ascopubs.org4d
LAPIS: Randomized phase 3 trial of chemotherapy (CTX) with and without pamrevlumab (PAM) for locally advanced pancreatic cancer (LAPC).
Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP ...
ascopubs.org2d
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...
ascopubs.org5d
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers BV combined with Len + R demonstrated significant improvements in overall survival (OS; 37% reduced risk of ...